Spondylitis clinical trials
The registry lists 43 studies for Spondylitis across more than 10 countries. 8 are recruiting or about to start. 3 of them are mainly about Spondylitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 7 narrower conditions too, such as Arthritis, Psoriatic: 1,311 studies, 277 open.
Get an email when these change. Save the Spondylitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Allina Health System (2) · AbbVie (2) · Istanbul Physical Medicine Rehabilitation Training and Research Hospital (2) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2) · University Hospital, Montpellier (2) · Novartis Pharmaceuticals (2) · AbbVie (prior sponsor, Abbott) (1) · Pfizer (1)
What is being tested here
Drugs under test in Spondylitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Secukinumab | 0 | 1 | 2 |
| Tofacitinib | 0 | 0 | 2 |
| Apremilast | 0 | 1 | 1 |
| Adalimumab | 0 | 1 | 1 |
| Aminocaproic Acid | 0 | 0 | 1 |
| Infliximab | 0 | 0 | 1 |
| Golimumab | 0 | 1 | 1 |
| Celecoxib | 0 | 0 | 1 |
| Naproxen | 0 | 0 | 1 |
| Meloxicam | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- May 2027Fecal Microbiota Transplantation in Axial Spondyloarthritis · University Hospital of North Norway
Who these studies take
Of the 5 Spondylitis studies recruiting now, 3 (60%) set no upper age limit and 2 (40%) stop at 75 or younger. 1 (20%) take children under 18. 0 (0%) are for women only and 1 (20%) for men only; 2 (40%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 4 (80%) | 5 (100%) |
| 30 | 4 (80%) | 5 (100%) |
| 40 | 4 (80%) | 5 (100%) |
| 50 | 4 (80%) | 5 (100%) |
| 65 | 4 (80%) | 5 (100%) |
| 75 | 3 (60%) | 3 (60%) |
| 85 | 3 (60%) | 3 (60%) |
Across all 43 studies, recruiting or not: 28% stop at 75 or younger and 23% at 65; 9% take children; 0% are for women only and 2% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 43 of 43. search them.
- Fecal Microbiota Transplantation in Axial SpondyloarthritisRecruitingNCT06451588Phase 21 country
- Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine SurgeryEnrolling by invitationNCT051108331 country
- Prolonged Bed Rest Versus Early Raising in Vertebral OsteomyelitisEnrolling by invitationNCT04735081
- Effects of a Digital Exercise Intervention on Sleep and Physical Activity in Patients With SpondyloarthritisNot yet recruitingNCT07034404Not applicable1 country
- Ultrasound Assessment of Neck Muscles and Balance in Male Patients With Ankylosing SpondylitisRecruitingNCT069678831 country
- Gene Expression Profiles in Spinal Tuberculosis.RecruitingNCT056100981 country
- axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial SpondyloarthritisRecruitingNCT06460805Not applicable1 country
- The Living With a Long-Term Condition StudyRecruitingNCT060722871 country
- Thoracic Mobility Versus Hip Mobility Exercises to Core Stabilization in Lumbar SpondylitisCompletedNCT07482527Not applicable1 country
- Modeling Spinal Mobility in Ankylosing Spondylitis: Towards New Telekinetic BiomarkersCompletedNCT05570656Not applicable1 country
- Proprio Spine Measurement ToolWithdrawnNCT07023393Not applicable1 country
- Evaluation of Outcomes of Surgical Treatment for Nonspecific Infectious Spondylodiscitis Via Posterior Approach in One Center.CompletedNCT07349602Not applicable1 country
- This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLECompletedNCT066989001 country
- Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 TrialsTerminatedNCT04115098Phase 21 country
- Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine SurgeryWithdrawnNCT05098431Not applicable1 country
- Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)CompletedNCT01327638
- Biologic National RegistryCompletedNCT037936601 country
- Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvementStatus unknownNCT04062695Phase 21 country
- Oral Vitamin D and Toll Like Receptor in Spondylitis TuberculosisStatus unknownNCT05376189Phase 2/31 country
- Effect of a Low Starch Diet in Patients With Ankylosing SpondylitisStatus unknownNCT04386538Not applicable1 country
- Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to PlaceboCompletedNCT02798211Phase 42 countries
- Work Productivity and Social Activities In Patients With Ankylosing SpondylitisCompletedNCT047495371 country
- Follow up Patients With Thoracolumbar Spondylodiscitis Surgically Treated by Posterior ApproachStatus unknownNCT04749082
- Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic TreatmentsStatus unknownNCT016427061 country
- Study of Apremilast to Treat Subjects With Active Ankylosing SpondylitisCompletedNCT01583374Phase 318 countries
- Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic ArthritisCompletedNCT02404350Phase 328 countries
- Burst Biologics Spinal Fusion RegistryStatus unknownNCT030648021 country
- Clinical Characteristics of Importance to Outcome in Patients With SpondyloarthritisStatus unknownNCT029486081 country
- Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858
- Tracking Biologics Along the Silk RoadCompletedNCT030061985 countries
- Sacroiliac Joint Fusion Comparison StudyWithdrawnNCT03230279Not applicable
- Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial SpondyloarthritisCompletedNCT01808118Phase 3
- Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility StudyStatus unknownNCT02873182Not applicable
- Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine SurgeryCompletedNCT00320619Not applicable1 country
- A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing SpondylitisStatus unknownNCT02809781Phase 2/31 country
- Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing SpondylitisCompletedNCT01786668Phase 210 countries
- Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing SpondylitisCompletedNCT00936143Phase 41 country
- A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisWithdrawnNCT01692457
- Qualitative Pain Measurement at Patients With Degenerative Low Back PainTerminatedNCT019805761 country
- Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With AdalimumabCompletedNCT012735191 country
- A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing SpondylitisCompletedNCT00265083Phase 39 countries
- Genetics of Ankylosing SpondylitisCompletedNCT000815621 country
- Blocking Tumor Necrosis Factor in Ankylosing SpondylitisCompletedNCT00000433Phase 21 country